Skip to main content
PatentCliff
A

Grade A Patent Portfolios

0 companies with exceptional patent strength

Grade A means exceptional patent portfolios with broad coverage, strong claims, and significant time remaining before expiration. Patent Strength Scores are calculated using USPTO PatentsView data.

0
Companies
0
Total Patents
0
Avg Score
0%
Of All Companies

All Grade A Companies

CompanyPatentsScoreExpiring 2yrExpiring 5yr

Frequently Asked Questions

Grade A (Exceptional) indicates exceptional patent portfolios with broad coverage, strong claims, and significant time remaining before expiration. The grade is based on portfolio size (30%), claims breadth (25%), time remaining (25%), and portfolio diversity (20%).

0 of 100 tracked companies currently have a Grade A Patent Strength Score, holding a combined 0 patents.

Grade A companies have strong IP protection. Their patent portfolios provide competitive moats, licensing revenue potential, and defensive positioning against competitors.

Sources: USPTO PatentsView
Last updated:

/methodology

The this entity category groups every U.S. pharmaceutical patent expirations entity sharing this attribute. The list above is the data; the paragraphs below explain what the grouping means against the broader the FDA Orange Book and USPTO patent records distribution and how to read the relative rankings within the category.

For readers using this category as a starting point, the per-entity detail pages linked from the table above carry the underlying the FDA Orange Book and USPTO patent records data in full. The category-level view is the filter; the per-entity pages are the actual answer.

Source: USPTO patent search, 2026.